Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05819411 · ClinicalTrials.gov registry record · NA
Intervention to Improve HIV Self-care Among People Who Inject Drugs
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT05819411: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05819411 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 42 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05819411, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
This study will implement a pilot randomized controlled trial (RCT, N=50) to refine and assess the feasibility and acceptability of an emotion regulation and communication skills intervention designed to improve engagement in HIV-care among HIV+ people who report opioid and/or stimulant use and are sub-optimally engaged in HIV care.
Interventions
- BEHAVIORAL Project iSTRIVE
- BEHAVIORAL incentivized Directly Observed Therapy (iDOT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05819411
The ClinicalTrials.gov registry entry for NCT05819411 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Project iSTRIVE is the first listed.
NCT05819411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05819411 about?
NCT05819411 is a clinical study titled "Intervention to Improve HIV Self-care Among People Who Inject Drugs". This study will implement a pilot randomized controlled trial (RCT, N=50) to refine and assess the feasibility and acceptability of an emotion regulation and communication skills intervention designed to improve engagement in HIV-care among HIV+ people who report opioid and/or stimulant use and are ...
What is the current status of trial NCT05819411?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2021-09-01. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT05819411?
The interventions under investigation include: Project iSTRIVE (BEHAVIORAL), incentivized Directly Observed Therapy (iDOT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05819411?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.